[Polycystic ovary syndrome II. Endocrinology and metabolism].
The polycystic ovary syndrome (PCOS) is diagnosed by the simultaneous presence of polycystic ovaries by ultrasound together with clinical and biochemical signs of hyperandrogenaemia. Recently, it has been shown that a majority of PCO patients exhibit metabolic abnormalities, i.e. android obesity, insulin resistance and dyslipidaemia, all of which dispose to "civilized" life-style diseases such as cardiovascular disease and non-insulin dependent diabetes. PCOS is therefore not merely a gynaecological curiosity, but an endocrinopathy with multisystem sequelae. The endocrinological and metabolic aspects of the disease are discussed.
Ovesen
P G
PG
Arhus Universitetshospital, Skejby Sygehus, gynaekologisk obstetrisk afdeling, og.
Møller
N
N
Greisen
S
S
Ingerslev
H J
HJ
D003937:Diagnosis, Differential; D005260:Female; D012739:Gonadal Steroid Hormones / Q000378:metabolism; D006801:Humans; D017588:Hyperandrogenism / Q000209:etiology / Q000378:metabolism; D010907:Pituitary Hormones / Q000378:metabolism; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000000981:diagnostic imaging / Q000378:metabolism*; D014463:Ultrasonography
D012739:Gonadal Steroid Hormones; D010907:Pituitary Hormones
Polycystisk ovarie-syndrome II. Endokrinologi og metabolisme.